Cargando…
Targeting the Siglec–Sialic Acid Immune Axis in Cancer: Current and Future Approaches
The sialic acid–binding immunoglobulin-like lectin (Siglec)–sialic acid immune axis is an evolutionarily conserved immunoregulatory pathway that provides a mechanism for establishing self-recognition and combatting invasive pathogens. Perturbations in the pathway lead to many immune dysregulated dis...
Autores principales: | Läubli, Heinz, Nalle, Sam C., Maslyar, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716255/ https://www.ncbi.nlm.nih.gov/pubmed/36264237 http://dx.doi.org/10.1158/2326-6066.CIR-22-0366 |
Ejemplares similares
-
Sialic Acid-Siglec Axis as Molecular Checkpoints Targeting of Immune System: Smart Players in Pathology and Conventional Therapy
por: Wielgat, Przemyslaw, et al.
Publicado: (2020) -
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
por: Lübbers, Joyce, et al.
Publicado: (2018) -
Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments
por: Gianchecchi, Elena, et al.
Publicado: (2021) -
Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021) -
Involvement of a Non-Human Sialic Acid in Human Cancer
por: Samraj, Annie N., et al.
Publicado: (2014)